×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)

AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)

货号:CL-0027

规格:1×10⁶cells/T25培养瓶

价格: ¥1400

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
  • AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确) ¥1400
AsPC-1细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1750¥1850

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 AsPC-1 (人转移胰腺腺癌细胞) (STR鉴定正确)
别称 AsPc-1; Aspc-1; ASPC-1; As-PC1; ASPC1; AsPC1; Aspc1; AsPc1
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 AsPC-1细胞来源于人胰腺癌病人腹水中的细胞裸鼠异种移植而产生的癌性腹水细胞;AsPC-1细胞可以表达CEA、人胰腺相关抗原、人胰腺特异性抗原和黏蛋白。
年龄(性别) 女性;62岁
组织来源 胰腺;转移灶;腹水腺癌
细胞类型 肿瘤细胞
肿瘤类型 胰腺癌细胞
生物安全等级 BSL-1
倍增时间 ~38-48 hours
基因表达情况 carcinoembryonic antigen (CEA); human pancreas associated antigen; human pancreas specific antigen; mucin
保藏机构 ATCC; CRL-1682 BCRC; 60494 ECACC; 96020930
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 10,13
    D2S1338 22,23
    D3S1358 16
    D5S818 12
    D7S820 12,13
    D8S1179 13,15
    D13S317 9,12
    D16S539 11
    D18S51 18
    D19S433 14
    D21S11 28,30
    FGA 24
    PentaD 9,12
    PentaE 5,12
    TH01 7,9.3
    TPOX 8,10
    vWA 17
    D6S1043 11,20
    D12S391 19
    D2S441 11,14
  • STR鉴定图
参考文献
文献列表
  • Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma (2024-02-26)

    作者:Yan Qin Tan:1.Institute of Biopharmaceutical and Health Engineering and Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, People's Republic of China. ; 2.Food Science and Technology Program, Department of Life Sciences, BNU-HKBU United International College, Zhuhai, 519087, Guangdong, People's Republic of China. ; Bowen Sun:1.Institute of Biopharmaceutical and Health Engineering and Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, People's Republic of China. ; Xi Zhang:1.Institute of Biopharmaceutical and Health Engineering and Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, People's Republic of China. ; 2.Shenzhen Bay Laboratory, Shenzhen, 518055, Guangdong, People's Republic of China. ; Shuwei Zhang:1.Institute of Biopharmaceutical and Health Engineering

    期刊:Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma

    DOI:10.1038/s41419-024-06551-7

    影响因子 :9.0

    引用产品: SW 1990 细胞 ,  PANC-1 细胞 ,  AsPC-1 细胞 ,  CFPAC-1 细胞

  • LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4 (2024-03-19)

    作者:Zhenchong Li:1.Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China. ; 2.Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. ; 3.Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. ; Zuyi Ma:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China. ; Shujie Wang:1.The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China. ; Qian Yan:1.Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. ; 2.South China Univer

    期刊:LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4

    DOI:10.1186/s13062-024-00463-4

    影响因子 :5.5

    引用产品: PANC-1 细胞 ,  BxPC-3 细胞 ,  Capan-2 细胞 ,  AsPC-1 细胞 ,  SW 1990 细胞 ,  HPED-6 细胞

  • Seratrodast platinum(IV) hybrids efficiently inhibit cancer-related thrombosis and metastasis phenotype in vitro and in vivo (2023-09-18)

    作者:Xue-Qing Song‡: 1.College of Pharmacy, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Hebei University, Baoding 071002, Hebei, P. R. China E-mail: sxqing@hbu.edu.cn, lilongfei@hbu.edu.cn; Yi-**n Ding‡: 1.College of Pharmacy, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Hebei University, Baoding 071002, Hebei, P. R. China E-mail: sxqing@hbu.edu.cn, lilongfei@hbu.edu.cn; Yu-Hang Zhang: 1.College of Pharmacy, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Key Laboratory of Medicina

    期刊:Seratrodast platinum(IV) hybrids efficiently inhibit cancer-related thrombosis and metastasis phenotype in vitro and in vivo

    DOI:10.1039/D3QI01328F

    影响因子 :7.0

    引用产品: A549 [A-549] 细胞 ,  A2780 细胞 ,  Hep G2 细胞 ,  AsPC-1 细胞 ,  HCT 116 细胞 ,  HK-2 细胞

  • 5′-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis (2023-10-12)

    作者:Wenpeng Cao:1.Department of Anatomy, School of Basic Medicine, Guizhou Medical University, Guiyang 550025, China. ; Zhirui Zeng:1.Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang 550025, China. ; Shan Lei:1.Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang 550025, China. ;

    期刊:5′-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis

    DOI:10.3390/biom13101513

    影响因子 :5.5

    引用产品: MIA PaCa-2 细胞 ,  PANC-1 细胞 ,  CFPAC-1 细胞 ,  Capan-2 细胞 ,  SW 1990 细胞 ,  BxPC-3 细胞 ,  AsPC-1 细胞 ,  人胰腺上皮细胞

  • Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2 (2023-07-24)

    作者:Wenpeng Cao:1.Department of Anatomy, School of Basic Medicine, Guizhou Medical University, Guiyang, China. ; Shisi Dai:1.Department of Anatomy, School of Basic Medicine, Guizhou Medical University, Guiyang, China. ; 2.Department of Anatomy, School of Basic Medicine, Guizhou Nursing Vocational college, Guiyang, China. ; Wanyuan Ruan:1.School of Clinical Medicine, Guizhou Medical University, Guiyang, China. ; Tingting Long:1.Department of Anatomy, School of Basic Medicine, Guizhou Medical University, Guiyang, China. ; Zhirui Zeng:1.Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, China. ; Shan Lei:1.Department of Physiology, School of Basic Medicine, Guizhou Medical University, Guiyang, China. ;

    期刊:Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2

    DOI:10.1111/jcmm.17852

    影响因子 :5.3

    引用产品: 人胰腺星状细胞 ,  AsPC-1 细胞 ,  PANC-1 细胞

  • KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma (2023-02-27)

    作者:Xing Huang:1.Department of General Surgery, Shengjing Hospital, China Medical University, Shenyang 110004, China. ; Feng Zhao:1.Department of Stem Cells and Regenerative Medicine, China Medical University, Shenyang 110122, China. ; Quan Wu:1.Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China. ; Zitong Wang:1.Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China. ; Haiyue Ren:1.Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China. ; Qiqi Zhang:1.Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China. ; Zhe Wang:1.Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China. ; Jin Xu:1.Department of General Surgery, Shengjing Hospital, China Medical University, Shenyang 110004, China. ;

    期刊:KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma

    DOI:10.3390/cancers15051502

    影响因子 :5.2

    引用产品: AsPC-1 细胞 ,  MIA PaCa-2 细胞

  • COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation (2023-02-26)

    作者:Yao Song:1.Department of Radiotherapy and Oncology, Affiliated Hospital of Nantong University, Nantong 226001, China. ; 2.Department of Radiation Oncology, Tenth People's Hospital Afflfliated to Tongji University, Shanghai 200072, China. ; Lei Wang:1.Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China. ; Kaidong Wang:1.Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China. ; Yuhua Lu:1.Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China. ; Pengcheng Zhou:1.Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China. ; 2.Department of Surgery, Medical School, Southeast University, Nanjing 210009, China. ;

    期刊:COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation

    DOI:10.3390/cancers15051480

    影响因子 :5.2

    引用产品: PANC-1 细胞 ,  BxPC-3 细胞 ,  CFPAC-1 细胞 ,  PATU8988 细胞 ,  AsPC-1 细胞 ,  MIA PaCa-2 细胞

  • Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers (2023-02-28)

    作者:Qihong Yang:1.State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; University of Chinese Academy of Sciences, Beijing, 100049, China. ; Tong Qin:1.State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100050, China. ; Tao An:1.State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China; School of Pharmaceutical Sciences, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, Shandong, China. ; Hongna Wu:1.State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100050, China. ; Gang Xu:1.Key Laboratory of Me

    期刊:Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers

    DOI:10.1016/j.ejphar.2023.175628

    影响因子 :5.0

    引用产品: AsPC-1 细胞 ,  HPAF-II 细胞 ,  PA-1 细胞 ,  NCCIT 细胞

  • Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer (2023-05-12)

    作者:Junliang Chen:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Zhihao Liu:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Zhiyuan Wu:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Wenjun Li:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Xiaodong Tan:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ;

    期刊:Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer

    DOI:10.3389/fonc.2023.1132424

    影响因子 :4.7

    引用产品: AsPC-1 细胞 ,  CFPAC-1 细胞 ,  PANC-1 细胞 ,  IMDM 培养基 ,  DMEM高糖 培养基 ,  特级胎牛血清 ,  青霉素-链霉素溶液 (双抗),100×

  • Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis (2023-10-30)

    作者:Zemin Zhu:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. ; Bo Yi:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. ; Zikai Tang:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. ; Xun Chen:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. ; 2.Department of Trauma Center, Zhuzhou Central Hospital, Zhuzhou, China. ; Ming Li:1.Department of Trauma Center, Zhuzhou Central Hospital, Zhuzhou, China. ; Tao Xu:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. ; Zhijian Zhao:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. zxyyzzj63@163.com. ; Caixi Tang:1.Department of Hepatobiliary and Pancreatic Surgery, Zhuzhou Central Hospital, Zhuzhou, China. tcx0864@163.com. ; 2.Department of Trauma Center, Zhuzhou Central

    期刊:Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis

    DOI:10.1186/s12885-023-11557-z

    影响因子 :3.8

    引用产品: MIA PaCa-2 细胞 ,  PANC-1 细胞 ,  AsPC-1 细胞 ,  BxPC-3 细胞 ,  THP-1 细胞 ,  DMEM高糖 培养基 ,  RPMI-1640 培养基 ,  特级胎牛血清 ,  马血清 ,  青霉素-链霉素溶液 (双抗),100× ,  β-巯基乙醇 (55mM),1000×

  • An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma (2023-08-31)

    作者:Shuguang Liu:1.Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen, 518033, China. liushg3@mail.sysu.edu.cn. ; Qianying Hu:1.Medical Research Center, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen, 518033, China. ; Zishan Xie:1.Department of Breast Surgery, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen, 518033, China. ; Shaojing Chen:1.Medical Research Center, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen, 518033, China. ; Yixuan Li:1.Medical Research Center, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen, 518033, China. ; Nali Quan:1.Clinical Laboratory, The Eighth Affiliated Hospital, Sun Yat-Sun University, Shenzhen, 518033, China. ; Kaimeng Huang:1.Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Kaimeng_huang@dfci.Harvard.edu. ; 2.CAS Key Laboratory of Regener

    期刊:An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma

    DOI:10.1007/s00432-023-05312-x

    影响因子 :3.6

    引用产品: AsPC-1 细胞

  • Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer (2023-02-12)

    作者:Jiaxing Du:1.Department of Surgical Oncology, Xinyang Central Hospital, Xinyang 464000, Henan Province, PR China. Electronic address: djx13131313@126.com. ; Yongsheng Chen:1.Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong Province, PR China. Electronic address: 318483790@qq.com. ; Genglong Liu:1.Department of Pathology, Shunde Hospital, Southern Medical University (The First people's hospital of Shunde), Foshan 528308, Guangdong Province, PR China; Baishideng Publishing Group Inc, Pleasanton, CA 94566, United States. Electronic address: lglong3@mail2.sysu.edu.cn. ; Qingxing Zeng:1.Department of Intensive Care Unit, Xinyang Central Hospital, Xinyang 464000, Henan Province, PR China. Electronic address: gszengxing@163.com. ; Nan Zhou:1.Department of Surgical Oncology, Xinyang Central Hospital, Xinyang 464000, Henan Province, PR China. Electronic address: ntzhounan@126.com. ; Dajun Du:1.Department o

    期刊:Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer

    DOI:10.1016/j.prp.2023.154374

    影响因子 :2.8

    引用产品: PANC-1 细胞 ,  MIA PaCa-2 细胞 ,  BxPC-3 细胞 ,  SW 1990 细胞 ,  AsPC-1 细胞

  • Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer (2022-08-04)

    作者:Lei Dou:1.School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, and Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, PR China. ; Huiqin Liu:1.School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, and Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, PR China. ; Kaixin Wang:1.School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, and Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, PR China. ; Jing Liu:1.MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, PR China. ; Lei Liu:1.School of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Structural Biology, and Key L

    期刊:Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer

    DOI:10.1016/j.jconrel.2022.07.033

    影响因子 :11.5

    引用产品: MIA PaCa-2 细胞 ,  BxPC-3 细胞 ,  AsPC-1 细胞 ,  SW 1990 细胞

  • ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway (2004-02-20)

    作者:Zuyi Ma:1.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. ; 2.Shantou University of Medical College, Shantou, 515000, China. ; Zhenchong Li:1.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. ; 2.South China University of Technology School of Medicine, Guangzhou, 51000, China. ; Shujie Wang:1.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. ; 2.The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China. ; Zixuan Zhou:1.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. ; 2.South China University of Technology School of Medicine, Guangzhou, 51000, China. ; Chunsheng Liu:1.Department of General Surgery, Guangd

    期刊:ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway

    DOI:10.1186/s13046-022-02310-8

    影响因子 :11.3

    引用产品: PANC-1 细胞 ,  BxPC-3 细胞 ,  Capan-2 细胞 ,  SW 1990 细胞 ,  AsPC-1 细胞

  • Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2 (2022-09-20)

    作者:Meijie Chen:1.Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang, China. ; Xuena Li:1.Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang, China. ; Bulin Du:1.Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang, China. ; Song Chen:1.Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang, China. ; Yaming Li:1.Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang, China. ;

    期刊:Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2

    DOI:10.1016/j.bcp.2022.115255

    影响因子 :6.1

    引用产品: PANC-1 细胞 ,  MIA PaCa-2 细胞 ,  BxPC-3 细胞 ,  AsPC-1 细胞 ,  CFPAC-1 细胞 ,  SW 1990 细胞 ,  CFPAC-1细胞专用培养基 ,  SW 1990细胞专用培养基 (L15)

  • GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma (2006-02-20)

    作者:Xiaoyuan Sun:1.Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, China. ; Huijun Chu:1.Department of Gynecology, Affiliated Hospital of Qingdao University, Qingdao, 266003, China. ; Ke Lei:1.Department of Gastroenterology, Center of Tumor Immunology and Cytotherapy, Medical Research Center, Affiliated Hospital of Qingdao University, Qingdao, 266003, China. ; Yandong Ci:1.Department of Orthopedics, Qingdao Eighth People's Hospital, Qingdao, 266003, China. ; Haijun Lu:1.Department of Radiation Oncology, Affiliated Hospital of Qingdao University, Qingdao, 266003, China. ; Jia Wang:1.Department of Gastroenterology, Center of Tumor Immunology and Cytotherapy, Medical Research Center, Affiliated Hospital of Qingdao University, Qingdao, 266003, China. ; Meng Zhou:1.Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, China. ; He Ren:1.Department of Gastroenterology, Center o

    期刊:GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma

    DOI:10.1016/j.pan.2022.06.006

    影响因子 :4.0

    引用产品: AsPC-1 细胞 ,  BxPC-3 细胞 ,  PANC-1 细胞 ,  MIA PaCa-2 细胞 ,  SW 1990 细胞

  • Cancer-associated fibroblast-secreted miR-421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF-1α axis (2022-10-06)

    作者:Bin Zhou:1.Department of Hepatobiliary and Pancreatic Surgery and Retroperitoneal Tumor Surgery, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China. ; Jing-Hao Lei:1.Department of Hepatobiliary and Pancreatic Surgery and Retroperitoneal Tumor Surgery, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China. ; Qiang Wang:1.Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. ; Teng-Fei Qu:1.Department of Hepatobiliary and Pancreatic Surgery and Retroperitoneal Tumor Surgery, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China. ; Li-Chao Cha:1.Department of Hepatobiliary and Pancreatic Surgery and Retroperitoneal Tumor Surgery, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China. ; Han-Xiang Zhan:1

    期刊:Cancer-associated fibroblast-secreted miR-421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF-1α axis

    DOI:10.1002/kjm2.12590

    影响因子 :3.0

    引用产品: PANC-1 细胞 ,  AsPC-1 细胞 ,  DMEM高糖 培养基 ,  RPMI-1640 培养基 ,  特级胎牛血清 ,  青霉素-链霉素溶液 (双抗),100×

  • CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer (2008-01-20)

    作者:Zixuan Zhou:1.South China University of Technology School of Medicine, Guangzhou 510006,Guangdong Province, China. ; 2.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China. ; Zuyi Ma:1.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China. ; 2.Shantou University of Medical College, Shantou 515000, China. ; Zhenchong Li:1.South China University of Technology School of Medicine, Guangzhou 510006,Guangdong Province, China. ; 2.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China. ; Hongkai Zhuang:1.Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China. ; 2.Shantou University of Medical College, Shantou 515000, China. ; Chunsheng Liu:1.Department of General Surgery, Gua

    期刊:CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer

    DOI:10.7150/jca.57082

    影响因子 :3.9

    引用产品: SW 1990 细胞 ,  AsPC-1 细胞 ,  PANC-1 细胞 ,  BxPC-3 细胞 ,  Capan-2 细胞

  • Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer (2007-01-20)

    作者:Jilong Hu:1.Department of Abdominal Surgery Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi 330029, China. ; Zhinan Zheng:1.Department of Pharmacy, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi 330029, China. ; Jia Lei:1.Haiyuan College, Kunming Medical University, Kunming, Yunnan 650106, China. ; Yuxin Cao:1.Department of Medicine, Nanchang University, Nanchang, Jiangxi 330000, China. ; Qiyun Li:1.Department of Abdominal Surgery Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi 330029, China. ; Zhi Zheng:1.Department of Internal Medicine 5th Division, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi 330029, China. ; Chuanjun Chen:1.Nanchang Royo Biotech Co., Ltd., Nanchang, Jiangxi 330029, China. ;

    期刊:Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer

    DOI:10.1155/2021/5589342

    影响因子 :2.9

    引用产品: PANC-1 细胞 ,  AsPC-1 细胞

  • MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation (2001-00-20)

    作者:Wenjie Huang:1.Department of First Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ; 2.Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China. ; Jianyou Gu:1.Department of First Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ; Tian Tao:1.Department of First Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ; Junfeng Zhang:1.Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China. ; 2.Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China. ; Huaizhi Wang:1.Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China. ; Yingfang Fan:1.Department of First Hepatobiliary Surgery, Zhujiang Hos

    期刊:MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation

    DOI:10.3389/fonc.2019.01499

    影响因子 :4.7

    引用产品: AsPC-1 细胞 ,  PANC-1 细胞

  • Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway (2003-00-20)

    作者:Xiangpeng Meng:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China. ; Jia Ma:1.Department of Gastrointestinal Endoscopy, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China. ; Baosheng Wang:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China. ; Xin Wu:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China. ; Zhen Liu:1.Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China. docliuz3@sina.com. ;

    期刊:Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway

    DOI:10.1007/s13105-020-00734-4

    影响因子 :3.4

    引用产品: AsPC-1 细胞 ,  PANC-1 细胞 ,  BxPC-3 细胞

  • Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells (2005-00-20)

    作者:Lei Zhang:1.First Department of General Surgery, Cangzhou Central Hospital , Cangzhou, Hebei, China. ; Zhenyong Wang:1.First Department of General Surgery, Cangzhou Central Hospital , Cangzhou, Hebei, China. ; Deshuai Kong:1.First Department of General Surgery, Cangzhou Central Hospital , Cangzhou, Hebei, China. ; Xiulei Zhao:1.First Department of General Surgery, Cangzhou Central Hospital , Cangzhou, Hebei, China. ; Xiongfei Chen:1.First Department of General Surgery, Cangzhou Central Hospital , Cangzhou, Hebei, China. ; Wei Chai:1.First Department of General Surgery, Cangzhou Central Hospital , Cangzhou, Hebei, China. ;

    期刊:Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells

    DOI:10.1080/09168451.2020.1762479

    影响因子 :1.6

    引用产品: PANC-1 细胞 ,  AsPC-1 细胞

  • miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression (2005-09-20)

    作者:Wenjie Huang:1.Department of First Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University Guangzhou 510280, Guangdong, China. ; 2.Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Army Medical University Chongqing 400038, China. ; Yaohuan Huang:1.Department of First Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University Guangzhou 510280, Guangdong, China. ; Jianyou Gu:1.Department of First Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University Guangzhou 510280, Guangdong, China. ; Junfeng Zhang:1.Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Army Medical University Chongqing 400038, China. ; Jiali Yang:1.Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Army Medical University Chongqing 400038, China. ; Songsong Liu:1.Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Army Medical University Chongqing 400038, China. ; Chuanming Xie:1.Institute of Hepatopancreatobiliary Surg

    期刊:miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression

    DOI:PMID:31217868

    影响因子 :2.2

    引用产品: AsPC-1 细胞 ,  CFPAC-1 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号